01—Abstract
Summary
Summary of the 8-K filed January 28, 2026. Cited figures are marked; the original filing is the authoritative source.
Archer-Daniels-Midland (ADM) has resolved its long-running investigations by the U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) relating to intersegment sales between its Nutrition segment and its Agriculture Services & Oilseeds and Carbohydrate Solutions segments.
On January 27, 2026, ADM announced a settlement with the SEC under which it, without admitting or denying wrongdoing, will pay a $40 milliona civil penalty and agree to cease and desist from future violations of specified federal securities laws. The company states the amount is not expected to have a material adverse effect on its results of operations or financial position. Separately, the DOJ notified ADM that it is no longer a subject of its investigation and has closed the matter with no further action.
For investors, the key takeaway is that the regulatory overhang tied to ADM's prior segment reporting has been removed. The filing indicates the underlying issues affected segment-level reporting only. According to the company, they had no impact on reported consolidated balance sheet, earnings, or cash flows for the periods presented in the restated filings.
ADM previously corrected prior-period errors in March 2024 and restated its 2023 Form 10-K and the first and second quarter 2024 Forms 10-Q in November 2024. The company also notes that it has made significant changes to its financial leadership team and financial controls.
The settlement's cease-and-desist terms are notable because they cover reporting and internal-controls provisions (Exchange Act Sections 13(a) and 13(b)(2)), which signals regulators' focus on the accuracy of periodic reporting going forward. Investors should weigh the closure of the enforcement matters against the continued need to monitor the effectiveness of ADM's remediated controls and segment disclosures, though the filing itself does not disclose any new financial results or guidance.
02—Key points
Key Highlights
- ADM agreed to pay a $40 million civil penalty to settle the SEC investigation, without admitting or denying wrongdoing.
- The DOJ notified ADM it is no longer a subject of its investigation and closed the matter with no further action, ending both government inquiries.
- The SEC settlement includes cease-and-desist orders covering Securities Act Section 17(a) and Exchange Act Sections 10(b), 13(a), and 13(b)(2)(A)-(B), plus related rules.
- ADM states the settlement is not expected to have a material adverse effect on its results of operations or financial position.
- The underlying issues concerned intersegment sales and segment-level reporting; ADM says there was no impact on reported consolidated balance sheet, earnings, or cash flows for the periods in the restated filings.
- Prior remediation included correcting prior-period errors in March 2024 and restating the 2023 Form 10-K and 2024 first and second quarter Forms 10-Q in November 2024.
- ADM reports significant changes to its financial leadership team and financial controls, and the CEO emphasized transparency and accurate financial reporting going forward.
03—Questions
Frequently Asked Questions
What was the subject of the SEC and DOJ investigations into ADM?
The investigations related to ADM's prior reporting of intersegment sales between its Nutrition segment and its Agriculture Services & Oilseeds and Carbohydrate Solutions segments. The issues concerned segment-level reporting accuracy.
How much is ADM paying to resolve the SEC matter, and does it admit wrongdoing?
ADM agreed to a $40 million civil penalty and to cease and desist from future violations of specified securities laws. It did so without admitting or denying any wrongdoing.
Did the restatements or the investigation affect ADM's reported financial results?
According to ADM, the transactions affected segment-level reporting only and had no impact on reported consolidated balance sheet, earnings, or cash flows for the periods presented in the restated filings.
Is the DOJ investigation still open?
No. The DOJ notified ADM that it is no longer a subject of its investigation and closed the matter with no further action, which ends both the SEC and DOJ investigations.
What should investors watch for after this settlement?
Investors may monitor the effectiveness of ADM's remediated financial controls and segment reporting, given the cease-and-desist undertakings covering periodic reporting and internal controls provisions. The filing itself contains no new financial results or guidance.
04—Continue